| Annual Financials | 2024 | 2025 | 2026 | TTM |
Revenue  | 24 | 46 | 42 | 0 |
| Expenses | 20 | 34 | 32 | 0 |
| EBITDA | 5 | 12 | 10 | 0 |
| Operating Profit % | 17 % | 25 % | 25 % | 0 % |
| Depreciation | 1 | 1 | 1 | 0 |
| Interest | 1 | 1 | 2 | 0 |
| Profit Before Tax | 3 | 10 | 8 | 0 |
| Tax | 1 | 3 | 2 | 0 |
| Net Profit | 2 | 7 | 6 | 0 |
| EPS in ₹ | 6.57 | 17.61 | 14.24 | 0.00 |
Avience Biomedicals
Avience Biomedicals
257.00
+10.30
(4.18%)
Market Cap
140.97 Cr
PE Ratio
15.46
Volume
66,000.00
Day High - Low
260.50 - 243.20
52W High-Low
414.95 - 208.00
Key Fundamentals
Market Cap
140.97 Cr
EPS
14.24
PE Ratio
15.46
PB Ratio
1.50
Book Value
164.88
EBITDA
10.34
Dividend Yield
0.00 %
Industry
- Sector
- Return on Equity
31.33
Debt to Equity
1.29
Actual
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
-8.85 %
Net Income Growth
-19.30 %
Cash Flow Change
232.35 %
ROE
-9.63 %
ROCE
19.47 %
EBITDA Margin (Avg.)
-6.81 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2024 | 2025 | 2026 |
| Total Assets | 35 | 57 | 78 |
| Fixed Assets | 10 | 13 | 29 |
| Current Assets | 23 | 37 | 47 |
| Capital Work in Progress | 0 | 5 | 13 |
| Investments | 0 | 0 | 17 |
| Other Assets | 24 | 39 | 0 |
| Total Equity & Liabilities | 35 | 57 | 78 |
| Current Liabilities | 21 | 24 | 33 |
| Non Current Liabilities | 8 | 10 | 14 |
| Total Equity | 6 | 23 | 31 |
| Reserve & Surplus | 3 | 19 | 27 |
| Share Capital | 3 | 4 | 4 |
Cash Flow
| Cash Flow | 2024 | 2025 |
| Net Cash Flow | 0 | 4 |
| Investing Activities | -4 | -10 |
| Operating Activities | 1 | 3 |
| Financing Activities | 3 | 10 |
Share Holding
| % Holding | Dec 2024 | Jul 2025 | Jun 2026 |
| Promoter | 92.85 % | 92.85 % | 64.59 % |
| FIIs | 0.00 % | 0.00 % | 3.06 % |
| DIIs | 0.00 % | 0.00 % | 9.08 % |
| Government | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 0.00 % | 13.57 % |
| Others | 7.15 % | 7.15 % | 9.69 % |
| No of Share Holders | 33 | 37 | 38 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 16 Jul 2026 |  Quarterly Result Announcement | NA | 16 Jul 2026 | 277.75 | 273.75 |
Technical Indicators
RSI(14)
Neutral 30.03
ATR(14)
Less Volatile 19.23
STOCH(9,6)
Neutral 59.07
STOCH RSI(14)
Oversold 0.00
MACD(12,26)
Bearish 0.00
ADX(14)
Weak Trend 0.00
UO(9)
Bullish 0.00
ROC(12)
Downtrend And Accelerating -6.12
WillR(14)
Neutral -52.70
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
